175 related articles for article (PubMed ID: 37908840)
1. TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.
McNair AJ; Markby GR; Tang Q; MacRae VE; Corcoran BM
Front Vet Sci; 2023; 10():1202001. PubMed ID: 37908840
[TBL] [Abstract][Full Text] [Related]
2. TGF-β-induced PI3K/AKT/mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease.
Tang Q; Markby GR; MacNair AJ; Tang K; Tkacz M; Parys M; Phadwal K; MacRae VE; Corcoran BM
Cell Prolif; 2023 Jun; 56(6):e13435. PubMed ID: 36869852
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
Tan K; Markby G; Muirhead R; Blake R; Bergeron L; Fici G; Summers K; Macrae V; Corcoran B
PLoS One; 2019; 14(8):e0221126. PubMed ID: 31415646
[TBL] [Abstract][Full Text] [Related]
4. Survival of activated myofibroblasts in canine myxomatous mitral valve disease and the role of apoptosis.
Blake RR; Markby GR; Culshaw GJ; Martinez-Pereira Y; Lu CC; Corcoran BM
Res Vet Sci; 2020 Feb; 128():99-106. PubMed ID: 31765842
[TBL] [Abstract][Full Text] [Related]
5. The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration.
Tang Q; McNair AJ; Phadwal K; Macrae VE; Corcoran BM
Front Cardiovasc Med; 2022; 9():872288. PubMed ID: 35656405
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and abundance of Bcl-2 family and transforming growth factor β1 signaling proteins in canine myxomatous mitral valves.
Surachetpong S; Jiranantasak T; Rungsipipat A; Orton EC
J Vet Cardiol; 2013 Sep; 15(3):171-80. PubMed ID: 23816827
[TBL] [Abstract][Full Text] [Related]
7. Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.
Thalji NM; Hagler MA; Zhang H; Casaclang-Verzosa G; Nair AA; Suri RM; Miller JD
Circ Cardiovasc Genet; 2015 Jun; 8(3):516-28. PubMed ID: 25814644
[TBL] [Abstract][Full Text] [Related]
8. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
[TBL] [Abstract][Full Text] [Related]
9. Disease Severity-Associated Gene Expression in Canine Myxomatous Mitral Valve Disease Is Dominated by TGFβ Signaling.
Markby GR; Macrae VE; Summers KM; Corcoran BM
Front Genet; 2020; 11():372. PubMed ID: 32395121
[TBL] [Abstract][Full Text] [Related]
10. Developmental pathways and endothelial to mesenchymal transition in canine myxomatous mitral valve disease.
Lu CC; Liu MM; Clinton M; Culshaw G; Argyle DJ; Corcoran BM
Vet J; 2015 Dec; 206(3):377-84. PubMed ID: 26586213
[TBL] [Abstract][Full Text] [Related]
11. [Transforming growth factor beta regulates hepatic progenitor cells migration via PI3K/AKT/mTOR/p70S6K pathway].
Pu XH; Li F; Miao XL; Ye JL; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):680-685. PubMed ID: 30481866
[No Abstract] [Full Text] [Related]
12. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix stiffness controls cardiac valve myofibroblast activation through epigenetic remodeling.
Walker CJ; Batan D; Bishop CT; Ramirez D; Aguado BA; Schroeder ME; Crocini C; Schwisow J; Moulton K; Macdougall L; Weiss RM; Allen MA; Dowell R; Leinwand LA; Anseth KS
Bioeng Transl Med; 2022 Sep; 7(3):e10394. PubMed ID: 36176599
[TBL] [Abstract][Full Text] [Related]
14. Gene network and canonical pathway analysis in canine myxomatous mitral valve disease: a microarray study.
Lu CC; Liu MM; Culshaw G; Clinton M; Argyle DJ; Corcoran BM
Vet J; 2015 Apr; 204(1):23-31. PubMed ID: 25841900
[TBL] [Abstract][Full Text] [Related]
15. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.
Aupperle H; Disatian S
J Vet Cardiol; 2012 Mar; 14(1):59-71. PubMed ID: 22364722
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-2 promotes in vitro mitral valve interstitial cell repair through transforming growth factor-β/Smad signaling.
Han L; Gotlieb AI
Am J Pathol; 2011 Jan; 178(1):119-27. PubMed ID: 21224050
[TBL] [Abstract][Full Text] [Related]
17. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers.
Geirsson A; Singh M; Ali R; Abbas H; Li W; Sanchez JA; Hashim S; Tellides G
Circulation; 2012 Sep; 126(11 Suppl 1):S189-97. PubMed ID: 22965982
[TBL] [Abstract][Full Text] [Related]
18. Culture and characterisation of canine mitral valve interstitial and endothelial cells.
Liu MM; Flanagan TC; Lu CC; French AT; Argyle DJ; Corcoran BM
Vet J; 2015 Apr; 204(1):32-9. PubMed ID: 25747697
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
[TBL] [Abstract][Full Text] [Related]
20. Aberrant TGFβ Signaling Contributes to Altered Trophoblast Differentiation in Preeclampsia.
Xu J; Sivasubramaniyam T; Yinon Y; Tagliaferro A; Ray J; Nevo O; Post M; Caniggia I
Endocrinology; 2016 Feb; 157(2):883-99. PubMed ID: 26653761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
